The region exhibits a distinct "African Paradox" with a lower frequency of the <i>PNPLA3</i> genetic risk variant (13.7%), which contributes to lower hepatic steatosis on imaging despite pronounced insulin resistance. The gene discussed is PNPLA3; the disease is fatty liver disease.